4.8 Review

Circulating Fibroblast Growth Factors as Metabolic Regulators-A Critical Appraisal

Journal

CELL METABOLISM
Volume 16, Issue 6, Pages 693-705

Publisher

CELL PRESS
DOI: 10.1016/j.cmet.2012.11.001

Keywords

-

Funding

  1. Swedish Research Council
  2. Stockholm City Council (ALF)
  3. Swedish Heart-Lung Foundation
  4. Swedish Diabetes Foundation
  5. Swedish Kidney Foundation
  6. Karolinska Institute
  7. Swedish Foundation for Strategic Research
  8. Cardiovascular Program, Karolinska Institute/Stockholm County Council
  9. Eli Lilly
  10. Albireo
  11. AstraZeneca
  12. KaroBio
  13. AB Albireo

Ask authors/readers for more resources

The circulating FGFs are a new group of proteins believed to function as classic hormones. With emphasis on human metabolism, we critically review current data, and propose that-although a number of questions remain-circulating FGF23 is pivotal in the control of phosphate and vitamin D metabolism, and may have additional systemic effects, particularly in chronic kidney disease; that FGF19 signaling is important for the regulation of bile acid metabolism, whereas its physiological role in promoting glucose and lipid metabolism is less well understood; and that the physiological role of circulating FGF21 in metabolic homeostasis warrants further investigation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available